Learning a business lessonClaire M. Fraser-Liggett said her knack for working with companies was helped by a business lesson in the early days at The Institute for Genomic Research. She found that getting funding and credit for discoveries was complicated by close ties with Human Genome Sciences Inc. Under an agreement, TIGR was sequencing genes and Human Genome Sciences would hold some property rights for development as a commercial company. Within a year, she said, the company signed a deal with giant pharma SmithKline Beecham. Human Genome Sciences and SmithKline Beecham ‘‘could take a small percentage of profit on what we were doing and keep it out of the public [domain],” she said. ‘‘I felt I was generating a lot of information that was fed into the SmithKline Beecham pipeline.” The Novartis collaboration is more successful, she said. ‘‘Now there was a strong effort by the Novartis system to get the information published and into the public domain.”
|
Top Jobs
Loading...
Classifieds |